Register today for ESCMID's new leadership course taking place in October! Designed for healthcare professionals, this 2-day course will help you build the practical leadership skills needed to navigate complexity, foster trust within teams, and drive meaningful change in healthcare.

Science & Research

ESCMID celebrates excellence in science with our various awards. The three excellence awards put a spotlight on those individuals with extraordinary contributions to the field of infection and ESCMID as a society. Nominations close soon on 21 August so don’t delay and nominate those individuals who you think deserve to be recognised by the scientific community.

Education

Join this intensive 3-day course co-organised with Ecraid designed for researchers using epidemiological and statistical methods and offering a programme that bridges advanced theory with hands-on project mentorship.

Drawing on clinical evidence and field experience, this course will examine how population movements influence disease epidemiology, the heightened risk of outbreaks in crisis-affected areas, and the limitations of conventional infectious disease control strategies in these contexts.

Congress & Events

Secure your accommodation in Stockholm through Congrex, the official accommodation partner for ESCMID Global 2027. A wide range of hotels are available at exclusive congress rates, with options to suit every budget.

Book early to secure your preferred hotel on the ESCMID website.

Guidelines & Journals

In the second edition of 'Quarterly catch-up', CMI Communications editors Emily McDonald and Erin McCreary round-up the biggest news in infectious diseases and review clinical microbiology and infectious diseases studies published in the second quarter of 2026.

Epi Alert: D.R. Congo reports 4,053 confirmed Ebola cases and 1,850 deaths across five provinces; Uganda declared its outbreak over on 28 July. Exported healthcare-worker cases occurred in Germany, Czechia, France, and the UK. West Nile virus, Europe: 241 locally acquired cases across seven European countries, led by Italy and Greece. Dengue, global situation: over 1.5 million cases globally, down from 2025. Chikungunya, global situation: 219,522 cases and 81 deaths across 25 countries, declining monthly. Zika virus: travel-linked cases from Fiji identified in US and New Zealand travellers. Measles: 47,459 confirmed cases in the Americas, an eightfold increase versus 2025.

Mutations in MRR1 that confer fluconazole resistance in C. parapsilosis and C. albicans confer cross-resistance to manogepixs

Should science and scientists explicitly repudiate war? An ESCMID Study Group for Infections in Travellers and Migrants (ESGITM) proposal to expand ethical declarations in scientific publishing